CLINICAL_TRIALS
trial_result
· 2023-12-22
Clinical Trial Update: A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety [Phase 3]
Summary
Phase III study completed evaluating the efficacy and safety of insulin aspart injection for diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd | Conditions: Diabetes | Phase 3 | Status: COMPLETED